<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Awaiting price reaction for this filing.
Cresanto Global Limited (formerly Raymed Labs Limited) has submitted a compliance disclosure to BSE confirming that it does not qualify as a 'Large Corporate' as of March 31, 2026, under SEBI regulations. The company stated that its outstanding borrowing as on that date is Nil. This filing is required under SEBI circulars governing debt securities issuance by large entities. The disclosure includes confirmation of no credit ratings as borrowing is zero. The company's Managing Director Prashant Nathmal Bajaj signed the filing dated April 21, 2026.
Neutral for shareholders as this is a routine regulatory compliance filing confirming the company falls below the threshold for Large Corporate classification, indicating manageable or minimal debt levels.